DocDollars

Amneal Pharmaceuticals LLC

NJ · United States · Reporting entity ID 100000126368

Total reported 2019–2025
$25.8M
#269 of 2,960 reporting companies — 0% of all reported industry payments
$10.6M in general payments across 110,874 records, plus $15.1M in research funding across 1,918 records.

How it breaks down

General payments $10,638,152
Research funding $15,131,716

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Amneal Pharmaceuticals LLC reported $25.8M to US doctors and teaching hospitals from 2019 to 2025, ranking #269 of 2,960 reporting companies. 59% of that was research funding and 41% general payments such as consulting, speaking, food and travel. 110,874 general payment records and 1,918 research records were filed.

Common questions about Amneal Pharmaceuticals LLC

How much has Amneal Pharmaceuticals LLC paid US doctors?

Amneal Pharmaceuticals LLC reported $25,769,868 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $10,638,152 in general payments, $15,131,716 in research funding.

How does Amneal Pharmaceuticals LLC rank among drug and device companies?

It ranks #269 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Amneal Pharmaceuticals LLC mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.